aTyr Pharma, Inc. (ATYR)

Oncternal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.22	11.06	22.54	9.98	2.34	16.95
Short-Term Investments	63.13	61.07	75.62	56.17	105.58	14.74
Cash & Short-Term Investments	80.35	72.13	98.17	66.15	107.91	31.69
Cash Growth	2.38%	-26.53%	48.41%	-38.70%	240.53%	1.75%
Other Receivables	0.5	1.74	2.44	11.78	0.44	0.04
Receivables	0.5	1.74	2.44	11.78	0.44	0.04
Prepaid Expenses	6.65	8.09	2.39	2.95	5.22	1.8
Other Current Assets	-	-	-	-	-	2
Total Current Assets	87.49	81.95	102.99	80.87	113.57	35.53
Property, Plant & Equipment	11.1	11.86	14.05	11.56	1.81	2.98
Other Long-Term Assets	2.94	3.02	3.62	3.36	0.16	0.21
Total Assets	101.53	96.83	120.65	95.79	115.54	38.73
Accounts Payable	3.88	4.32	3.53	3.11	1.03	1.43
Accrued Expenses	10.32	9.39	11.56	9.86	4	3.57
Current Portion of Leases	1.33	1.25	1.33	0.89	0.98	0.86
Total Current Liabilities	15.53	14.97	16.42	13.86	6.01	5.86
Long-Term Leases	11.35	12.03	13.77	10.64	0.4	1.38
Total Liabilities	26.88	27	30.18	24.5	6.41	7.24
Common Stock	0.09	0.08	0.06	0.03	0.03	0.01
Additional Paid-In Capital	641.28	602.02	558.69	489.5	481.83	370.21
Retained Earnings	-566.46	-532.05	-468.02	-417.63	-372.3	-338.53
Comprehensive Income & Other	-0.08	-0.04	-0.07	-0.43	-0.26	-0.04
Total Common Equity	74.85	70.02	90.66	71.46	109.3	31.65
Minority Interest	-0.19	-0.19	-0.19	-0.18	-0.18	-0.17
Shareholders' Equity	74.66	69.83	90.47	71.28	109.13	31.48
Total Liabilities & Equity	101.53	96.83	120.65	95.79	115.54	38.73
Total Debt	12.68	13.28	15.1	11.53	1.38	2.24
Net Cash (Debt)	67.67	58.84	83.07	54.61	106.53	29.45
Net Cash Growth	4.70%	-29.17%	52.11%	-48.74%	261.74%	51.70%
Net Cash Per Share	0.81	0.79	1.55	1.92	5.58	3.21
Filing Date Shares Outstanding	97.99	88.86	67.75	53.16	27.8	16.01
Total Common Shares Outstanding	92.87	84.04	63.29	29.5	27.79	11.02
Working Capital	71.96	66.99	86.58	67.01	107.56	29.67
Book Value Per Share	0.81	0.83	1.43	2.42	3.93	2.87
Tangible Book Value	74.85	70.02	90.66	71.46	109.3	31.65
Tangible Book Value Per Share	0.81	0.83	1.43	2.42	3.93	2.87
Machinery	-	3.74	4.5	5	5	5.82
Leasehold Improvements	-	5.65	5.65	4.41	1.7	1.7

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q